Literature DB >> 8746763

Acute MPTP treatment produces no changes in mitochondrial complex activities and indices of oxidative damage in the common marmoset ex vivo one week after exposure to the toxin.

M Gerlach1, M Götz, A Dirr, A Kupsch, B Janetzky, W Oertel, J Sautter, J Schwarz, H Reichmann, P Riederer.   

Abstract

1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) has been shown to cause a Parkinsonian syndrome in man and non-human primates. Hypotheses concerning the pathogenetic mechanisms of MPTP toxicity on nigro-striatal dopaminergic neurons relate to impairment of mitochondrial function and oxidative stress. However, surprisingly few primate studies addressed these issues ex vivo. Thus, the present study assessed the enzyme activities of the respiratory chain, GSH/GSSG and ubiquinol/ubiquinone content in the MPTP primate model (common marmoset, Callithrix jacchus; 2 mg MPTP-hydrochloride/kg body wt were injected subcutaneously (s.c.) on four consecutive days; animals were sacrificed 7 days after last MPTP exposure). Activities of respiratory chain enzymes were measured in crude homogenates of the caudate nucleus, because the probable toxic metabolite of MPTP, MPP+, is transported into dopaminergic neurons via the dopamine uptake system in striatal synapses and mitochondria are concentrated in axonal terminals. Since MPP+ can damage membranes of axonal terminals of nigro-striatal neurons we measured GSH/GSSG contents in the putamen and ubiquinol/ubiquinone concentrations in the substantia nigra and putamen as indices of oxidative damage. At the time of sacrifice MPTP-induced deficits comprised severe behavioural Parkinsonian symptoms, profound depletion of striatal dopamine and its major metabolites as well as pronounced loss of nigro-striatal neurons. Despite these severe lesions, acute MPTP treatment had no effect on any of the enzymes of the respiratory chain in the caudate nucleus and indices of oxidative damage in both the substantia nigra and putamen. These results suggest that factors other than mitochondrial impairment and/or oxidative stress may be involved in MPTP neurotoxicity in primates. Alternatively, early compensatory mechanisms and/or transient effects could account for the reported results and will be discussed.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8746763     DOI: 10.1016/0197-0186(95)00063-e

Source DB:  PubMed          Journal:  Neurochem Int        ISSN: 0197-0186            Impact factor:   3.921


  7 in total

Review 1.  The role of iron in neurodegeneration: prospects for pharmacotherapy of Parkinson's disease.

Authors:  K A Jellinger
Journal:  Drugs Aging       Date:  1999-02       Impact factor: 3.923

2.  Distinct mechanisms underlie neurotoxin-mediated cell death in cultured dopaminergic neurons.

Authors:  J Lotharius; L L Dugan; K L O'Malley
Journal:  J Neurosci       Date:  1999-02-15       Impact factor: 6.167

Review 3.  Animal models of Parkinson's disease: an empirical comparison with the phenomenology of the disease in man.

Authors:  M Gerlach; P Riederer
Journal:  J Neural Transm (Vienna)       Date:  1996       Impact factor: 3.575

4.  Excessive iron accumulation in the brain: a possible potential risk of neurodegeneration in Parkinson's disease.

Authors:  J Lan; D H Jiang
Journal:  J Neural Transm (Vienna)       Date:  1997       Impact factor: 3.575

5.  Reduction of lipid peroxidation in different brain regions by a combination of alpha-tocopherol and ascorbic acid.

Authors:  S Bano; M S Parihar
Journal:  J Neural Transm (Vienna)       Date:  1997       Impact factor: 3.575

Review 6.  Potential therapeutic properties of green tea polyphenols in Parkinson's disease.

Authors:  Tianhong Pan; Joseph Jankovic; Weidong Le
Journal:  Drugs Aging       Date:  2003       Impact factor: 3.923

Review 7.  Mitochondria-Endoplasmic Reticulum Crosstalk in Parkinson's Disease: The Role of Brain Renin Angiotensin System Components.

Authors:  Tuladhar Sunanda; Bipul Ray; Arehally M Mahalakshmi; Abid Bhat; Luay Rashan; Wiramon Rungratanawanich; Byoung-Joon Song; Musthafa Mohamed Essa; Meena Kishore Sakharkar; Saravana Babu Chidambaram
Journal:  Biomolecules       Date:  2021-11-10
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.